Mutation research · 1995
Adriamycin-inducible proteins associated with drug sensitivity in resistant immunoblastic B lymphoma cells.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chao C C, Yam W C, Chung K C, Ho Y S
Аннотация
We have previously established an immunoblastic B lymphoma cell line, designated HOB1. This cell line is hypersensitive to a wide spectrum of chemotherapeutic agents. Two co-regulated polypeptides around 64 kDa (termed p64) were induced 10-30-fold in response to adriamycin and some other drugs at the IC50 (the concentration inhibiting cell growth by 50%). These inducible proteins are localized as monomeric forms in the cytosolic fraction, with isoelectric points of pH = 6.2 (major protein) and pH = 7.0 (minor protein). An adriamycin-resistant cell line was established from HOB1 cells. The p64 inducibility was dramatically reduced in resistant HOB1 cells or unrelated cell lines which show phenotypic resistance to adriamycin toxicity. The loss of p64 inducibility in resistant cells is not due to a failure of cells to take up adriamycin since drug accumulation kinetics remained the same as in the parental cells.
Предметные рубрики MeSH
Antibodies, NeoplasmAntineoplastic AgentsBiological TransportBlotting, WesternCell FractionationCytosolDose-Response Relationship, DrugDoxorubicinDrug ResistanceGene Expression Regulation, NeoplasticHeLa CellsHumansLymphoma, B-CellNeoplasm ProteinsPrecursor Cell Lymphoblastic Leukemia-LymphomaTumor Cells, Cultured